Top

Published in:

01-06-2017 | Review

Diagnostic work-up and specific causes of acute kidney injury

Authors: Michael Darmon, Marlies Ostermann, Jorge Cerda, Meletios A. Dimopoulos, Lui Forni, Eric Hoste, Matthieu Legrand, Nicolas Lerolle, Eric Rondeau, Antoine Schneider, Bertrand Souweine, Miet Schetz

Published in: Intensive Care Medicine | Issue 6/2017

Abstract

Acute kidney injury (AKI) is common in critically ill patients and associated with grim short- and long-term outcome. Although in the vast majority of cases AKI is multifactorial, with sepsis, shock and nephrotoxicity accounting for most episodes, specific causes of AKI are not uncommon. Despite remaining uncertainties regarding their prevalence in the ICU, prompt recognition of specific aetiologies of AKI is likely to ensure timely management, limit worsening of renal dysfunction, and ultimately limit renal and systemic consequences of AKI. The ability to recognize conditions that may be associated with specific aetiologies and the appropriate use of clinical imaging, biological and immunological tests, along with optimal assessment of the need for renal biopsies, should be part of routine ICU care. In this review, we summarize uncertainties, current knowledge and recent advances regarding specific types of AKI. We describe the most common specific causes as well as rare aetiologies requiring urgent management, and outline available tools that may be used during the diagnostic work-up along with their limitations.

Available only for authorised users

Hoste EAJ, Bagshaw SM, Bellomo R et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423. doi:10.1007/s00134-015-3934-7 CrossRefPubMed

Chawla LS, Eggers PW, Star RA, Kimmel PL (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371:58–66. doi:10.1056/NEJMra1214243 CrossRefPubMed

Nisula S, Kaukonen K-M, Vaara ST et al (2013) Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med 39:420–428. doi:10.1007/s00134-012-2796-5 CrossRefPubMed

Kidney Disease: Improving Global, Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2:1–138CrossRef

Chawla LS, Bellomo R, Bihorac A et al (2017) Expert consensus document Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol (in press)

Haase-Fielitz A, Haase M, Devarajan P (2014) Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann Clin Biochem 51:335–351. doi:10.1177/0004563214521795 CrossRefPubMedPubMedCentral

Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:1CrossRef

Vandenberghe W, De Loor J, Hoste EAJ (2017) Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkers. Curr Opin Anaesthesiol 30:66–75. doi:10.1097/ACO.0000000000000419 PubMed

Koyner JL, Shaw AD, Chawla LS et al (2015) Tissue inhibitor metalloproteinase-2 (TIMP-2) IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol JASN 26:1747–1754. doi:10.1681/ASN.2014060556 CrossRefPubMed

10.

Schneider AG, Bellomo R (2013) Urinalysis and pre-renal acute kidney injury: time to move on. Crit Care Lond Engl 17:141. doi:10.1186/cc12676 CrossRef

11.

Darmon M, Vincent F, Dellamonica J et al (2011) Diagnostic performance of fractional excretion of urea in the evaluation of critically ill patients with acute kidney injury: a multicenter cohort study. Crit Care Lond Engl 15:R178. doi:10.1186/cc10327 CrossRef

12.

Pons B, Lautrette A, Oziel J et al (2013) Diagnostic accuracy of early urinary index changes in differentiating transient from persistent acute kidney injury in critically ill patients: multicenter cohort study. Crit Care Lond Engl 17:R56. doi:10.1186/cc12582 CrossRef

13.

Nejat M, Pickering JW, Devarajan P et al (2012) Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int. doi:10.1038/ki.2012.23 PubMedPubMedCentral

14.

Vanmassenhove J, Glorieux G, Hoste E et al (2013) Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis. Crit Care Lond Engl 17:R234. doi:10.1186/cc13057 CrossRef

15.

Faubel S, Patel NU, Lockhart ME, Cadnapaphornchai MA (2014) Renal relevant radiology: use of ultrasonography in patients with AKI. Clin J Am Soc Nephrol 9:382–394. doi:10.2215/CJN.04840513 CrossRefPubMed

16.

Barozzi L, Valentino M, Santoro A et al (2007) Renal ultrasonography in critically ill patients. Crit Care Med 35:S198–S205. doi:10.1097/01.CCM.0000260631.62219.B9 CrossRefPubMed

17.

Schnell D, Reynaud M, Venot M, et al (2014) Resistive index or color-Doppler semi-quantitative evaluation of renal perfusion by inexperienced physicians: results of a pilot study. Miner Anestesiol 80:1273–1281

18.

Schnell D, Darmon M (2012) Renal Doppler to assess renal perfusion in the critically ill: a reappraisal. Intensive Care Med 38:1751–1760. doi:10.1007/s00134-012-2692-z CrossRefPubMed

19.

Deruddre S, Cheisson G, Mazoit J-X et al (2007) Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography. Intensive Care Med 33:1557–1562. doi:10.1007/s00134-007-0665-4 CrossRefPubMed

20.

Ichai C, Vinsonneau C, Souweine B et al (2016) Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies). Ann Intensive Care 6:48. doi:10.1186/s13613-016-0145-5 CrossRefPubMedPubMedCentral

21.

Schneider AG, Hofmann L, Wuerzner G et al (2012) Renal perfusion evaluation with contrast-enhanced ultrasonography. Nephrol Dial Transplant 27:674–681. doi:10.1093/ndt/gfr345 CrossRefPubMed

22.

Schneider AG, Goodwin MD, Schelleman A et al (2013) Contrast-enhanced ultrasound to evaluate changes in renal cortical perfusion around cardiac surgery: a pilot study. Crit Care Lond Engl 17:R138. doi:10.1186/cc12817 CrossRef

23.

Schneider AG, Goodwin MD, Schelleman A et al (2014) Contrast-enhanced ultrasonography to evaluate changes in renal cortical microcirculation induced by noradrenaline: a pilot study. Crit Care Lond Engl 18:653. doi:10.1186/s13054-014-0653-3 CrossRef

24.

Martinez-Suarez HJ, Durso T, Kadlec AO et al (2015) Three-dimensional renal parenchymal volume as a surrogate for renal function estimation in obstructed kidneys undergoing surgical repair. J Endourol 29:630–633. doi:10.1089/end.2014.0232 CrossRefPubMed

25.

Kaewlai R, Abujudeh H (2012) Nephrogenic systemic fibrosis. Am J Roentgenol 199:W17–W23. doi:10.2214/AJR.11.8144 CrossRef

26.

Prowle JR, Molan MP, Hornsey E, Bellomo R (2012) Measurement of renal blood flow by phase-contrast magnetic resonance imaging during septic acute kidney injury: a pilot investigation. Crit Care Med 40:1768–1776. doi:10.1097/CCM.0b013e318246bd85 CrossRefPubMed

27.

Chu R, Li C, Wang S et al (2014) Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease. Clin J Am Soc Nephrol 9:1175–1182. doi:10.2215/CJN.06150613 CrossRefPubMedPubMedCentral

28.

Philipponnet C, Guérin C, Canet E et al (2013) Kidney biopsy in the critically ill patient, results of a multicentre retrospective case series. Miner Anestesiol 79:53–61

29.

Brachemi S, Bollée G (2014) Renal biopsy practice: what is the gold standard? World J Nephrol 3:287–294. doi:10.5527/wjn.v3.i4.287 CrossRefPubMedPubMedCentral

30.

Stratta P, Canavese C, Marengo M et al (2007) Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur J Clin Invest 37:954–963. doi:10.1111/j.1365-2362.2007.01885.x CrossRefPubMed

31.

Augusto J-F, Lassalle V, Fillatre P et al (2012) Safety and diagnostic yield of renal biopsy in the intensive care unit. Intensive Care Med 38:1826–1833. doi:10.1007/s00134-012-2634-9 CrossRefPubMed

32.

Chodak GW, Gill WB, Wald V, Spargo B (1983) Diagnosis of renal parenchymal diseases by a modified open kidney biopsy technique. Kidney Int 24:804–806CrossRefPubMed

33.

Shetye KR, Kavoussi LR, Ramakumar S et al (2003) Laparoscopic renal biopsy: a 9-year experience. BJU Int 91:817–820CrossRefPubMed

34.

Thompson BC, Kingdon E, Johnston M et al (2004) Transjugular kidney biopsy. Am J Kidney Dis 43:651–662CrossRefPubMed

35.

Mischak H (2015) Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures! Nephrol Dial Transplant 30:532–537. doi:10.1093/ndt/gfv046 CrossRefPubMed

36.

Chavez LO, Leon M, Einav S, Varon J (2016) Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care Lond Engl 20:135. doi:10.1186/s13054-016-1314-5 CrossRef

37.

Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11. doi:10.1002/art.37715 CrossRefPubMed

38.

Liaño F, Pascual J (1996) Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50:811–818CrossRefPubMed

39.

Uezono S, Hara S, Sato Y et al (2006) Renal biopsy in elderly patients: a clinicopathological analysis. Renal Fail 28:549–555. doi:10.1080/08860220600840165 CrossRef

40.

Dumas G, Géri G, Montlahuc C et al (2015) Outcomes in critically ill patients with systemic rheumatic disease: a multicenter study. Chest 148:927–935. doi:10.1378/chest.14-3098 CrossRefPubMed

41.

Kimmoun A, Baux E, Das V et al (2016) Outcomes of patients admitted to intensive care units for acute manifestation of small-vessel vasculitis: a multicenter, retrospective study. Crit Care Lond Engl 20:27. doi:10.1186/s13054-016-1189-5 CrossRef

42.

Lerolle N, Nochy D, Guérot E et al (2010) Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 36:471–478. doi:10.1007/s00134-009-1723-x CrossRefPubMed

43.

de Prost N, Parrot A, Cuquemelle E et al (2012) Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisited. Respir Med 106:1021–1032. doi:10.1016/j.rmed.2012.03.015 CrossRefPubMed

44.

Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221–232. doi:10.1056/NEJMoa0909905 CrossRefPubMedPubMedCentral

45.

Specks U, Merkel PA, Seo P et al (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 369:417–427. doi:10.1056/NEJMoa1213277 CrossRefPubMed

46.

Praga M, Sevillano A, Auñón P, González E (2015) Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant 30:1472–1479. doi:10.1093/ndt/gfu326 CrossRefPubMed

47.

Raghavan R, Eknoyan G (2014) Acute interstitial nephritis—a reappraisal and update. Clin Nephrol 82:149–162CrossRefPubMedPubMedCentral

48.

Krishnan N, Perazella MA (2015) Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment. Iran J Kidney Dis 9:3–13PubMed

49.

Bagshaw SM, Laupland KB, Doig CJ et al (2005) Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care Lond Engl 9:R700–R709. doi:10.1186/cc3879 CrossRef

50.

Darmon M, Vincent F, Canet E et al (2015) Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie. Nephrol Dial Transplant 30:2006–2013. doi:10.1093/ndt/gfv372 CrossRefPubMedPubMedCentral

51.

Soares M, Salluh JIF, Carvalho MS et al (2006) Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 24:4003–4010. doi:10.1200/JCO.2006.05.7869 CrossRefPubMed

52.

Darmon M, Vincent F, Camous L et al (2013) Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique. Br J Haematol 162:489–497. doi:10.1111/bjh.12415 CrossRefPubMed

53.

Coiffier B, Altman A, Pui C-H et al (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26:2767–2778. doi:10.1200/JCO.2007.15.0177 CrossRefPubMed

54.

Dimopoulos MA, Terpos E, Chanan-Khan A et al (2010) Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 28:4976–4984. doi:10.1200/JCO.2010.30.8791 CrossRefPubMed

55.

Dimopoulos MA, Roussou M, Gavriatopoulou M et al (2016) Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis. Am J Hematol 91:499–502. doi:10.1002/ajh.24335 CrossRefPubMed

56.

Hutchison CA, Batuman V, Behrens J et al (2011) The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol 8:43–51. doi:10.1038/nrneph.2011.168 CrossRefPubMedPubMedCentral

57.

Gerth J, Sachse A, Busch M et al (2012) Screening and differential diagnosis of renal light chain-associated diseases. Kidney Blood Press Res 35:120–128. doi:10.1159/000330715 CrossRefPubMed

58.

Leung N, Gertz M, Kyle RA et al (2012) Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases. Clin J Am Soc Nephrol 7:1964–1968. doi:10.2215/CJN.11161111 CrossRefPubMedPubMedCentral

59.

Hutchison CA, Bradwell AR, Cook M et al (2009) Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 4:745–754. doi:10.2215/CJN.04590908 CrossRefPubMedPubMedCentral

60.

Bridoux F, Pegourie B, Augel-Meunier K, et al (2016) Treatment of myeloma cast nephropathy (MCN): a randomized trial comparing intensive haemodialysis (HD) with high cut-off (HCO) or standard high-flux dialyzer in patients receiving a Bortezomib-based regimen (the MYRE Study, by the Intergroupe Francophone du Myélome (IFM) and the French Society of Nephrology (SFNDT). Blood 978

61.

Cook M, Hutchison CA, Fifer L, et al (2016) High cut-off haemodialysis(HCO-HD) does not improve outcomes in myeloma cast nephropathy: results of European trial of Free Light Chain removal extended haemodialysis in cast nephropathy(EULITE). EHA P270

62.

Mannucci PM (2015) Understanding organ dysfunction in thrombotic thrombocytopenic purpura. Intensive Care Med 41:715–718. doi:10.1007/s00134-014-3630-z CrossRefPubMed

63.

George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654–666. doi:10.1056/NEJMra1312353 CrossRefPubMed

64.

Fremeaux-Bacchi V, Fakhouri F, Garnier A et al (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8:554–562. doi:10.2215/CJN.04760512 CrossRefPubMedPubMedCentral

65.

Fakhouri F, Vercel C, Frémeaux-Bacchi V (2012) Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol 7:2100–2106. doi:10.2215/CJN.13121211 CrossRefPubMed

66.

Stella CL, Dacus J, Guzman E et al (2009) The diagnostic dilemma of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the obstetric triage and emergency department: lessons from 4 tertiary hospitals. Am J Obstet Gynecol 200:381.e1–381.e6. doi:10.1016/j.ajog.2008.10.037 CrossRef

67.

Pourrat O, Coudroy R, Pierre F (2015) Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators. Eur J Obstet Gynecol Reprod Biol 189:68–72. doi:10.1016/j.ejogrb.2015.03.017 CrossRefPubMed

68.

Thomas MR, Robinson S, Scully MA (2016) How we manage thrombotic microangiopathies in pregnancy. Br J Haematol 173:821–830. doi:10.1111/bjh.14045 CrossRefPubMed

69.

Mehta RL, Cerdá J, Burdmann EA et al (2015) International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385:2616–2643. doi:10.1016/S0140-6736(15)60126-X CrossRefPubMed

70.

Swanepoel CR, Wearne N, Okpechi IG (2013) Nephrology in Africa—not yet uhuru. Nat Rev Nephrol 9:610–622. doi:10.1038/nrneph.2013.168 CrossRefPubMed

71.

Lewington AJP, Cerdá J, Mehta RL (2013) Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 84:457–467. doi:10.1038/ki.2013.153 CrossRefPubMedPubMedCentral

72.

Mehta RL, Burdmann EA, Cerdá J et al (2016) Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet Lond Engl 387:2017–2025. doi:10.1016/S0140-6736(16)30240-9 CrossRef

73.

Basu G, Chrispal A, Boorugu H et al (2011) Acute kidney injury in tropical acute febrile illness in a tertiary care centre—RIFLE criteria validation. Nephrol Dial Transplant 26:524–531. doi:10.1093/ndt/gfq477 CrossRefPubMed

74.

Cerdá J, Bagga A, Kher V, Chakravarthi RM (2008) The contrasting characteristics of acute kidney injury in developed and developing countries. Nat Clin Pract Nephrol 4:138–153. doi:10.1038/ncpneph0722 CrossRefPubMed

75.

Prakash J, Pant P, Singh AK et al (2015) Renal cortical necrosis is a disappearing entity in obstetric acute kidney injury in developing countries: our three decade of experience from India. Ren Fail 37:1185–1189. doi:10.3109/0886022X.2015.1062340 CrossRefPubMed

76.

Perazella MA (2015) The urine sediment as a biomarker of kidney disease. Am J Kidney Dis 66:748–755. doi:10.1053/j.ajkd.2015.02.342 CrossRefPubMed

77.

Shephard MD (2011) Point-of-care testing and creatinine measurement. Clin Biochem Rev 32:109–114PubMedPubMedCentral

78.

McDonald RJ, McDonald JS, Bida JP et al (2013) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 267:106–118. doi:10.1148/radiol.12121823 CrossRefPubMed

79.

Takasu O, Gaut JP, Watanabe E et al (2013) Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med 187:509–517. doi:10.1164/rccm.201211-1983OC CrossRefPubMedPubMedCentral

80.

Langenberg C, Gobe G, Hood S et al (2014) Renal histopathology during experimental septic acute kidney injury and recovery. Crit Care Med 42:e58–e67. doi:10.1097/CCM.0b013e3182a639da CrossRefPubMed

81.

Langenberg C, Bagshaw SM, May CN, Bellomo R (2008) The histopathology of septic acute kidney injury: a systematic review. Crit Care Lond Engl 12:R38. doi:10.1186/cc6823 CrossRef

Title: Diagnostic work-up and specific causes of acute kidney injury
Authors: Michael Darmon
Marlies Ostermann
Jorge Cerda
Meletios A. Dimopoulos
Lui Forni
Eric Hoste
Matthieu Legrand
Nicolas Lerolle
Eric Rondeau
Antoine Schneider
Bertrand Souweine
Miet Schetz
Publication date: 01-06-2017
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 6/2017
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-017-4799-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Diagnostic work-up and specific causes of acute kidney injury

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2017

Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017

Focus on infection and sepsis 2017

How to improve the care of patients with acute kidney injury

Video laryngoscopy for ICU intubation: a meta-analysis of randomised trials

Renal recovery after acute kidney injury

Cold agglutinin disease: an unusual cause of shock in the ICU